{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:24:30Z","timestamp":1790907870382,"version":"4.1.0"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:p>Hyperkalemia is a potentially life-threatening electrolyte disorder appreciated with greater frequency in patients with renal disease, heart failure, and with use of certain medications such as renin angiotensin aldosterone inhibitors. The traditional views that hyperkalemia can be reliably diagnosed by electrocardiogram and that particular levels of hyperkalemia confer cardiotoxic risk have been challenged by several reports of patients with atypic presentations. Epidemiologic data demonstrate strong associations of morbidity and mortality in patients with hyperkalemia but these associations appear disconnected in certain patient populations and in differing clinical presentations. Physiologic adaptation, structural cardiac disease, medication use, and degree of concurrent illness might predispose certain patients presenting with hyperkalemia to a lower or higher threshold for toxicity. These factors are often overlooked; yet data suggest that the clinical context in which hyperkalemia develops is at least as important as the degree of hyperkalemia is in determining patient outcome. This review summarizes the clinical data linking hyperkalemia with poor outcomes and discusses how the efficacy of certain treatments might depend on the clinical presentation.<\/jats:p>","DOI":"10.1681\/asn.2016121344","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T21:00:25Z","timestamp":1501880425000},"page":"3155-3165","source":"Crossref","is-referenced-by-count":193,"title":["How Dangerous Is Hyperkalemia?"],"prefix":"10.1681","volume":"28","author":[{"given":"John R.","family":"Montford","sequence":"first","affiliation":[{"name":"Division of Renal Disease and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado;"},{"name":"Renal Section, Medicine Service, Veterans Affairs Eastern Colorado Health System, Denver, Colorado; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Linas","sequence":"additional","affiliation":[{"name":"Division of Renal Disease and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado;"},{"name":"Division of Nephrology, Department of Medicine, Denver Health and Hospitals, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"B1-20231016","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.","volume":"7","author":"Sarafidis","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2-20231016","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease.","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.","volume":"5","author":"Weir","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ajkd.2012.02.328","article-title":"Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: A nested case-control study.","volume":"60","author":"Lafrance","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3181\/00379727-149-38765","article-title":"Cardiac sensitivity to hyperkalemia in adrenalectomized dogs.","volume":"149","author":"Hiatt","year":"1975","journal-title":"Proc Soc Exp Biol Med"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2460\/ajvr.1970.31.11.2001","article-title":"Effects of potassium intoxication on porcine electrocardiograms.","volume":"31","author":"Coulter","year":"1970","journal-title":"Am J Vet Res"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.CIR.47.2.408","article-title":"Relation of electrolyte disturbances to cardiac arrhythmias.","volume":"47","author":"Fisch","year":"1973","journal-title":"Circulation"},{"key":"B8-20231016","first-page":"233","article-title":"Electrolyte disorders and arrhythmogenesis.","volume":"18","author":"El-Sherif","year":"2011","journal-title":"Cardiol J"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-8703(67)90233-5","article-title":"Relationship between electrocardiogram and electrolytes.","volume":"73","author":"Surawicz","year":"1967","journal-title":"Am Heart J"},{"issue":"Suppl","key":"B10-20231016","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.4097\/kjae.2010.59.S.S124","article-title":"Cardiac arrest from acute hyperkalemia during liver surgery -A case report-.","volume":"59","author":"Lee","year":"2010","journal-title":"Korean J Anesthesiol"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.64.3.358","article-title":"Cardiac arrest due to hyperkalemia following intravenous penicillin administration.","volume":"64","author":"Mercer","year":"1973","journal-title":"Chest"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0030-1253520","article-title":"Hyperkalemia, bradycardia, and cardiac arrest during percutaneous declotting of an arteriovenous graft.","volume":"27","author":"Wiltrout","year":"2010","journal-title":"Semin Intervent Radiol"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajhp\/60.7.694","article-title":"Cardiac arrest from succinylcholine-induced hyperkalemia.","volume":"60","author":"Huggins","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/1097-0142(197705)39:5<2290::AID-CNCR2820390550>3.0.CO;2-P","article-title":"Cardiac arrest due to hyperkalemia following therapy for acute lymphoblastic leukemia.","volume":"39","author":"Wilson","year":"1977","journal-title":"Cancer"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0002-9343(48)90162-4","article-title":"Relation of abnormalities in concentration of serum potassium to electrocardiographic disturbances.","volume":"5","author":"Tarail","year":"1948","journal-title":"Am J Med"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.158.8.917","article-title":"Hyperkalemia in hospitalized patients: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.","volume":"158","author":"Acker","year":"1998","journal-title":"Arch Intern Med"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2215\/CJN.04611007","article-title":"Retrospective review of the frequency of ECG changes in hyperkalemia.","volume":"3","author":"Montague","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B18-20231016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/ndt\/gfs129","article-title":"The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease.","volume":"28","author":"Green","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jelectrocard.2013.07.012","article-title":"Recurrent life-threatening hyperkalemia without typical electrocardiographic changes.","volume":"47","author":"Khattak","year":"2014","journal-title":"J Electrocardiol"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0002-9149(97)89197-7","article-title":"Atypical electrocardiographic changes in severe hyperkalemia.","volume":"77","author":"Yu","year":"1996","journal-title":"Am J Cardiol"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-0736(99)90020-1","article-title":"Severe hyperkalemia with minimal electrocardiographic manifestations: A report of seven cases.","volume":"32","author":"Martinez-Vea","year":"1999","journal-title":"J Electrocardiol"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9343(76)90334-X","article-title":"Unusual electrocardiographic finding--bifascicular block due to hyperkalemia.","volume":"61","author":"O\u2019Neil","year":"1976","journal-title":"Am J Med"},{"key":"B23-20231016","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0736-4679(88)90410-6","article-title":"Pseudomyocardial infarction and hyperkalemia: A case report and subject review.","volume":"6","author":"Simon","year":"1988","journal-title":"J Emerg Med"},{"key":"B24-20231016","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/0022-3859.138828","article-title":"Hyperkalemia induced pseudo-myocardial infarction in septic shock.","volume":"60","author":"Pothiawala","year":"2014","journal-title":"J Postgrad Med"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0272-6386(86)80185-8","article-title":"Profound hyperkalemia without electrocardiographic manifestations.","volume":"7","author":"Szerlip","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MAJ.0b013e318279b105","article-title":"Management of hyperkalemia in hospitalized patients.","volume":"347","author":"Fordjour","year":"2014","journal-title":"Am J Med Sci"},{"key":"B27-20231016","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00003246-198905000-00005","article-title":"Tall T waves during metabolic acidosis without hyperkalemia: A prospective study.","volume":"17","author":"Dreyfuss","year":"1989","journal-title":"Crit Care Med"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/hrt.67.4.304","article-title":"Variable patterns of ST-T abnormalities in patients with left ventricular hypertrophy and normal coronary arteries.","volume":"67","author":"Huwez","year":"1992","journal-title":"Br Heart J"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0736-4679(99)00010-4","article-title":"Electrocardiographic manifestations: Benign early repolarization.","volume":"17","author":"Brady","year":"1999","journal-title":"J Emerg Med"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/ajem.2002.32630","article-title":"The prominent T wave: Electrocardiographic differential diagnosis.","volume":"20","author":"Somers","year":"2002","journal-title":"Am J Emerg Med"},{"key":"B31-20231016","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc11872","article-title":"Severe hyperkalemia requiring hospitalization: Predictors of mortality.","volume":"16","author":"An","year":"2012","journal-title":"Crit Care"},{"key":"B32-20231016","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s00134-012-2636-7","article-title":"Association between hyperkalemia at critical care initiation and mortality.","volume":"38","author":"McMahon","year":"2012","journal-title":"Intensive Care Med"},{"key":"B33-20231016","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5114\/aoms.2014.42577","article-title":"Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.","volume":"10","author":"Khanagavi","year":"2014","journal-title":"Arch Med Sci"},{"key":"B34-20231016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0167-5273(91)90295-Z","article-title":"Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction.","volume":"32","author":"Friedensohn","year":"1991","journal-title":"Int J Cardiol"},{"key":"B35-20231016","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.CIR.61.4.768","article-title":"Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine.","volume":"61","author":"Hill","year":"1980","journal-title":"Circulation"},{"key":"B36-20231016","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.CIR.77.5.1125","article-title":"Distribution of extracellular potassium and its relation to electrophysiologic changes during acute myocardial ischemia in the isolated perfused porcine heart.","volume":"77","author":"Coronel","year":"1988","journal-title":"Circulation"},{"key":"B37-20231016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2011.1967","article-title":"Serum potassium levels and mortality in acute myocardial infarction.","volume":"307","author":"Goyal","year":"2012","journal-title":"JAMA"},{"key":"B38-20231016","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.amjmed.2016.03.008","article-title":"Prevalence and prognosis of hyperkalemia in patients with acute myocardial Infarction.","volume":"129","author":"Grodzinsky","year":"2016","journal-title":"Am J Med"},{"key":"B39-20231016","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ehjcvp\/pvv026","article-title":"Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction.","volume":"1","author":"Krogager","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B40-20231016","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0272-6386(96)90465-5","article-title":"Impact of the initial levels of laboratory variables on survival in chronic dialysis patients.","volume":"28","author":"Iseki","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"B41-20231016","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients.","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B42-20231016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000448341","article-title":"Serum potassium levels and mortality in hemodialysis patients: A Retrospective Cohort study.","volume":"44","author":"Yusuf","year":"2016","journal-title":"Am J Nephrol"},{"key":"B43-20231016","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2215\/CJN.00960112","article-title":"Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort.","volume":"7","author":"Torl\u00e9n","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B44-20231016","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/ndt\/gfp104","article-title":"Sudden death and associated factors in a historical cohort of chronic haemodialysis patients.","volume":"24","author":"Genovesi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B45-20231016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2016.10.024","article-title":"Serum potassium and short-term clinical outcomes among hemodialysis patients: Impact of the long interdialytic interval.","volume":"70","author":"Brunelli","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B46-20231016","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000437151","article-title":"Serum potassium, end-stage renal disease and mortality in chronic kidney disease.","volume":"41","author":"Nakhoul","year":"2015","journal-title":"Am J Nephrol"},{"key":"B47-20231016","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2215\/CJN.05850809","article-title":"Serum potassium and outcomes in CKD: Insights from the RRI-CKD cohort study.","volume":"5","author":"Korgaonkar","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B48-20231016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1755.2002.00350.x","article-title":"Hyperkalemia: An adaptive response in chronic renal insufficiency.","volume":"62","author":"Gennari","year":"2002","journal-title":"Kidney Int"},{"key":"B49-20231016","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0272-6386(12)80110-7","article-title":"Extrarenal potassium tolerance in chronic renal failure: Implications for the treatment of acute hyperkalemia.","volume":"18","author":"Salem","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"B50-20231016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/cs0730247","article-title":"Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis.","volume":"73","author":"Sandle","year":"1987","journal-title":"Clin Sci (Lond)"},{"key":"B51-20231016","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MNH.0b013e32826fbc7d","article-title":"BK channels in the kidney.","volume":"16","author":"Grimm","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B52-20231016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0016-5085(85)80130-X","article-title":"Role of aldosterone and dietary potassium in potassium adaptation in the distal colon of the rat.","volume":"88","author":"Foster","year":"1985","journal-title":"Gastroenterology"},{"key":"B53-20231016","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1469-7793.1997.537bm.x","article-title":"Characterization of apical potassium channels induced in rat distal colon during potassium adaptation.","volume":"501","author":"Butterfield","year":"1997","journal-title":"J Physiol"},{"key":"B54-20231016","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.07761109","article-title":"Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.","volume":"5","author":"Foley","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B55-20231016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2215\/CJN.06020612","article-title":"A longitudinal study of left ventricular function and structure from CKD to ESRD: The CRIC study.","volume":"8","author":"Bansal","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B56-20231016","doi-asserted-by":"crossref","first-page":"e001303","DOI":"10.1161\/JAHA.114.001303","article-title":"Incident atrial fibrillation and risk of death in adults with chronic kidney disease.","volume":"3","author":"Bansal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B57-20231016","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC).","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"B58-20231016","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000357200","article-title":"Heart rate variability is a predictor of mortality in chronic kidney disease: A report from the CRIC Study.","volume":"38","author":"Drawz","year":"2013","journal-title":"Am J Nephrol"},{"key":"B59-20231016","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors.","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"},{"key":"B60-20231016","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/ndt\/gfr684","article-title":"Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.","volume":"27","author":"Rizk","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B61-20231016","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1681\/ASN.V1061297","article-title":"QT dispersion in patients with end-stage renal failure and during hemodialysis.","volume":"10","author":"Lorincz","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B62-20231016","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.2013.186","article-title":"Pulmonary hypertension in patients with chronic and end-stage kidney disease.","volume":"84","author":"Sise","year":"2013","journal-title":"Kidney Int"},{"key":"B63-20231016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.krcp.2015.01.003","article-title":"Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients.","volume":"34","author":"Kim","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"B64-20231016","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0196-0644(96)70012-4","article-title":"Hyperkalemia and digoxin toxicity in a patient with kidney failure.","volume":"28","author":"Fenton","year":"1996","journal-title":"Ann Emerg Med"},{"key":"B65-20231016","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/0886022X.2016.1216714","article-title":"Community-acquired hyperkalemia in elderly patients: Risk factors and clinical outcomes.","volume":"38","author":"Turgutalp","year":"2016","journal-title":"Ren Fail"},{"key":"B66-20231016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000442393","article-title":"Prevalence of hyperkalemia in diabetic and non-diabetic patients with chronic kidney disease: A Nested Case-Control study.","volume":"42","author":"Loutradis","year":"2015","journal-title":"Am J Nephrol"},{"key":"B67-20231016","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: A randomized controlled trial.","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B68-20231016","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"B69-20231016","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"B70-20231016","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"B71-20231016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.113.000792","article-title":"Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).","volume":"7","author":"Rossignol","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B72-20231016","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2012.01.367","article-title":"Predictors of hyperkalemia and death in patients with cardiac and renal disease.","volume":"109","author":"Jain","year":"2012","journal-title":"Am J Cardiol"},{"key":"B73-20231016","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2017.03.080","article-title":"Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.","volume":"238","author":"Tseng","year":"2017","journal-title":"Int J Cardiol"},{"key":"B74-20231016","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.ajkd.2005.06.013","article-title":"Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.","volume":"46","author":"Muto","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B75-20231016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrneph.2011.175","article-title":"Diuretic use in renal disease.","volume":"8","author":"Sica","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B76-20231016","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2215\/CJN.03640415","article-title":"Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD.","volume":"10","author":"Lepage","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B77-20231016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"B78-20231016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: The AMETHYST-DN randomized clinical trial.","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"B79-20231016","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia.","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"key":"B80-20231016","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial.","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"B81-20231016","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"key":"B82-20231016","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ki.1980.14","article-title":"Hyperkalemia and hyporeninemic hypoaldosteronism.","volume":"17","author":"DeFronzo","year":"1980","journal-title":"Kidney Int"},{"key":"B83-20231016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.V281279","article-title":"Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine.","volume":"2","author":"Kamel","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"B84-20231016","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/dme.13359","article-title":"Fludrocortisone therapy for persistent hyperkalaemia.","volume":"34","author":"Dobbin","year":"2017","journal-title":"Diabet Med"},{"key":"B85-20231016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/1319-2442.124539","article-title":"Role of fludrocortisone in the management of tacrolimus-induced hyperkalemia in a renal transplant recipient.","volume":"25","author":"Sivakumar","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B86-20231016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4212\/cjhp.v64i6.1091","article-title":"Fludrocortisone for heparin-induced hyperkalemia.","volume":"64","author":"Brown","year":"2011","journal-title":"Can J Hosp Pharm"},{"key":"B87-20231016","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.ajkd.2006.01.014","article-title":"A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.","volume":"47","author":"Kaisar","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B88-20231016","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/ndt\/gfm386","article-title":"Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.","volume":"22","author":"Kim","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"B90-20231016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000360807","article-title":"Calcinosis cutis confined to the dermis after intravenous administration of a calcium preparation: A case report and review of the Japanese literature.","volume":"6","author":"Watanabe","year":"2014","journal-title":"Case Rep Dermatol"},{"issue":"Suppl 2","key":"B91-20231016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0560.2006.00519.x","article-title":"Calcinosis cutis: A complication of intravenous administration of calcium glucanate.","volume":"33","author":"Moss","year":"2006","journal-title":"J Cutan Pathol"},{"key":"B92-20231016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ki.1990.200","article-title":"Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure.","volume":"38","author":"Conte","year":"1990","journal-title":"Kidney Int"},{"key":"B93-20231016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2369-15-56","article-title":"Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy.","volume":"15","author":"Chang","year":"2014","journal-title":"BMC Nephrol"},{"key":"B94-20231016","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-112-7-492","article-title":"Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study.","volume":"112","author":"Cooper","year":"1990","journal-title":"Ann Intern Med"},{"key":"B95-20231016","first-page":"108","article-title":"Hypocalcemia complicating bicarbonate therapy for salicylate poisoning.","volume":"141","author":"Fox","year":"1984","journal-title":"West J Med"},{"key":"B96-20231016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11255-014-0820-0","article-title":"Sodium bicarbonate infusion for prevention of acute kidney injury: No evidence for superior benefit, but risk for harm?","volume":"47","author":"Schiffl","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"B97-20231016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.kjms.2010.12.010","article-title":"Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: Case report and literature review.","volume":"27","author":"Chou","year":"2011","journal-title":"Kaohsiung J Med Sci"},{"key":"B98-20231016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/SMJ.0b013e31819e8978","article-title":"Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.","volume":"102","author":"McGowan","year":"2009","journal-title":"South Med J"},{"key":"B99-20231016","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1111\/j.1600-6143.2012.04225.x","article-title":"Small intestinal transplant mucosal necrosis associated with enteral sodium polystyrene sulfonate administration.","volume":"12","author":"Saginur","year":"2012","journal-title":"Am J Transplant"},{"key":"B100-20231016","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01170216","article-title":"Effect of patiromer on urinary ion excretion in healthy adults.","volume":"11","author":"Bushinsky","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B101-20231016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archinte.1981.00340020029012","article-title":"Severe hypokalemia induced by hemodialysis.","volume":"141","author":"Wiegand","year":"1981","journal-title":"Arch Intern Med"},{"key":"B102-20231016","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2215\/CJN.08850811","article-title":"Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns study.","volume":"7","author":"Jadoul","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B103-20231016","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1980.93","article-title":"Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients.","volume":"17","author":"Morrison","year":"1980","journal-title":"Kidney Int"},{"issue":"Pt A","key":"B104-20231016","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.phrs.2016.09.039","article-title":"Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future.","volume":"113","author":"Rossignol","year":"2016","journal-title":"Pharmacol Res"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201711000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:45:45Z","timestamp":1786131945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201711000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016121344","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}